PHARMACON FORSCHUNG & BERATUNG GMBH has a total of 29 patent applications. Its first patent ever was published in 1996. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are ZHEJIANG HISUN PHARM CO LTD, MEDIVIR AB and GALILEO LAB INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | China | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Austria | 3 | |
#5 | Canada | 3 | |
#6 | United States | 3 | |
#7 | Republic of Korea | 2 | |
#8 | Australia | 1 | |
#9 | Israel | 1 | |
#10 | Norway | 1 | |
#11 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Sugars | |
#4 | Steroids | |
#5 | Medical preparations | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Jasic Muhamed | 12 |
#2 | Noe Christian R | 12 |
#3 | Kollmann Hermann | 10 |
#4 | Lachmann Bodo | 10 |
#5 | Noe Christian | 8 |
#6 | Saadat Karmin | 5 |
#7 | Kollmann Herbert | 3 |
#8 | Zobl Karin | 3 |
#9 | Weigand-Becker Antje | 2 |
#10 | Hermann Kollmann | 2 |
Publication | Filing date | Title |
---|---|---|
CN101484162A | Use of combination preparations comprising antifungal agents | |
CA2615832A1 | Method for producing nebivolol | |
AT503319A1 | Use of stereoisomerine pure chinuclidinium salts of cycloalkyl aryl glycolate starters for the manufacture of medicaments | |
AT502221A1 | Homogemic citabine, process for their production and their use | |
WO2005066195A1 | Method for producing 1,2-unsaturated azasteroids | |
ATA18962002A | Method for producing the r, r or s, s configured glycopyrronium isomers | |
WO03016259A2 | Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances |